Indigenous people living in Canada have rates of kidney disease that are 3 times higher than the non-Indigenous Canadian population, yet no studies have specifically examined patterns of kidney disease among Métis citizens living in Ontario.
What this adds
The risk of kidney disease may be similar or slightly higher among Métis citizens of Ontario compared with the general population matched on age, sex, and area of residence.
Background
Indigenous peoples living in Canada have rates of kidney disease that are 3 times higher than non-Indigenous Canadians. 1 The reasons for this are complex and multifactorial, but may include a genetic predisposition 2 and limited access to culturally appropriate primary health care.
1 As well, a history of disadvantage in Canadian society may have contributed to a higher prevalence of low birth weight, which is associated with reduced nephron endowment, [3] [4] [5] postinfectious glomerulonephritis, 6 ,7 obesity, early-onset diabetes, and increased vascular disease. 1 Métis people are a unique Indigenous community with their own values, beliefs, traditions, culture, language, territory, and history. There are approximately 86 000 Métis people living in Ontario, which comprise about 30% of the total Indigenous population in Canada. 8 The Métis are the fastest growing Indigenous population in Canada. 9 Historically, Métis people are descendants of Aboriginal women and European men. To our knowledge, no prior reports have examined the patterns of kidney disease among Métis people residing in Canada. At the request of the Métis Nation of Ontario (MNO), we developed a research partnership to examine kidney disease and related outcomes in this unique population. Our objective was to compare the prevalence of chronic kidney disease, the incidence of acute kidney injury, and end-stage kidney disease among registered Métis citizens of Ontario with the general Ontario population matched on age, sex, and geographic area of residence. We also examined 1-year outcomes among those hospitalized with acute kidney injury.
Methods

Design and Setting
Ontario has a population of 13 million individuals with universal health care covering both emergency and preventive care. The MNO is a Métis-specific governance body that was established in 1993 to represent Métis citizens and communities in Ontario. The MNO maintains a citizenship registry which currently captures approximately 18 000 individuals or 20% of the provincial Métis population. To apply as a citizen, one must meet the Métis National Council's National Definition for Citizenship within the Métis Nation: "Métis means a person who selfidentifies as Métis, is distinct from other Aboriginal peoples, is of historic Métis Nation ancestry, and is accepted by the Métis Nation." 10 We conducted a retrospective, population-based cohort study using the MNO citizenship registry, current as of 2009, which we linked to Ontario's administrative data held at the Institute for Clinical Evaluative Sciences (ICES). This research was commissioned by the MNO and was conducted through the provincial ICES Kidney, Dialysis and Transplantation Research Program. This research uses the recommended policies for the ethical conduct of research involving Indigenous peoples. 11 It is offered in a spirit of respect. Data sets were linked using unique encoded identifiers and analyzed at ICES Western, London, Ontario, Canada. This study was pre-approved by the institutional review board at Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. The reporting of this study follows the checklist of recommendations for reporting of observational studies using the REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement (see Appendix A). 12 
Data Sources
We used the MNO citizenship registry to create a cohort of registered Métis citizens in Ontario who were alive as of April 1, 2003. We used 7 other linked databases held at ICES to examine study outcomes during follow-up (April 1, 2003, to March 31, 2012). The Canadian Institute for Health Information (CIHI) Discharge Abstract Database and the National Ambulatory Care Reporting System Database contain diagnostic and procedural information for all hospital admissions and emergency department visits in Ontario. The Ontario Health Insurance Plan (OHIP) Claims Database captures physician billing claims for inpatient, outpatient, and laboratory services rendered to all persons in Ontario. The Registered Persons Database includes birth, death, and demographic information for all Ontario residents. The Ontario portion of the Canadian Organ Replacement Register (CORR) contains information on all organ transplantation types and dialysis. We also linked laboratory data from 2 sources to obtain kidney function laboratory test results (serum creatinine) for our cohort. The Dynacare Database includes outpatient laboratory tests for a large commercial lab provider with locations across Ontario. Twelve hospitals in Southwestern Ontario share a common electronic medical record (Cerner, Missouri, USA) which contains inpatient, emergency department, and outpatient laboratory testing.
Cohort Selection
We performed initial data cleaning to exclude individuals with invalid identifiers or with missing date of birth or sex ( Figure 1 ). We also excluded non-Ontario residents, individuals who were younger than 18 years as of April 1, 2003, and patients with previous end-stage kidney disease (defined as chronic dialysis 1 year before April 1, 2003, or a kidney transplant in the 5-year period before April 1, 2003). To assess the incidence of acute kidney injury during follow-up, we further excluded patients with evidence of pre-existing chronic kidney disease (defined as 1 or more codes for chronic kidney disease in the year before April 1, 2003; codes provided in Appendix B).
We matched eligible Métis citizens to individuals from the general Ontario population, using a 1-to-4 ratio, on age (±2 years), sex, census dissemination area (a proxy for geographical location of residence describing populations of 400 to 700 individuals), and evidence of a baseline outpatient serum creatinine measurement in the year prior to April 1, 2003. To avoid overmatching, we did not match on diabetes or other comorbidities because these conditions may be a mechanism of kidney disease in some individuals. Hereafter, the matched sample from the general Ontario population is referred to as the general population.
Measures and Outcomes
Baseline characteristics. We measured the following demographic characteristics in both cohorts: sex, income quintile, geographic location, and age. We also gathered baseline information on health care use in the year before April 1, 2003 (nephrologist visits, primary care visits, and hospitalizations), and presence of comorbidities in the 5 years before April 1, 2003 (diabetes, myocardial infarction and stroke).
Chronic kidney disease. We defined the prevalence of chronic kidney disease in 2 ways: (1) point prevalence at baseline estimated using outpatient serum creatinine in the year before April 1, 2003, and (2) period prevalence during follow-up (April 1, 2003, to March 31, 2012) using diagnostic codes. Prevalence at baseline was estimated by looking for at least one serum creatinine value in the previous year (if a person had multiple tests, then we used the most recent value). Estimated glomerular filtration rate (eGFR) was calculated using the Chronic Kidney Disease Epidemiology Collaboration equation. 13 This calculation assumed no individuals were of black race because we lacked data on this variable; however, less than 5% of Ontarians are black. 9 Severity of chronic kidney disease was defined as mild (60 > eGFR ≥ 45mL/min/1.73 m 2 ) or moderate to severe (eGFR < 45mL/min/1.73 m 2 ). Given the low number of patients with albuminuria measurements in our data sets, we did not use albumin-to-creatinine ratios to define chronic kidney disease.
The prevalence of chronic kidney disease during follow-up was estimated based on the presence of at least one validated administrative diagnostic code (codes provided in Appendix B). 14 We originally planned to assess outcomes for chronic kidney disease, including end-stage kidney disease; however, event rates were too small to report.
Acute kidney injury. The incidence of acute kidney injury during follow-up was estimated after excluding those with one or more codes for chronic kidney disease in the year before April 1, 2003. Acute kidney injury was defined in 2 ways: (1) a rise in serum creatinine >50% or >27 µmol/L from an outpatient baseline value 15 and (2) the presence of a diagnostic code in hospital for acute kidney injury. For the first definition, we identified all patients with a serum creatinine value measured during follow-up (either in the emergency department or as an inpatient); we then selected the highest creatinine value and compared this with the most recent value taken during the year before April 1, 2003.
For the second definition, we defined acute kidney injury using validated administrative diagnostic codes in hospital (Appendix B). 16 One-year outcomes after acute kidney injury. Among patients with acute kidney injury defined using diagnostic codes, we examined the following outcomes (up to March 31, 2013): (1) duration of hospital stay, (2) death during hospitalization, (3) short-term dialysis during hospitalization, (4) death within 1 year of hospital discharge, and (5) nonrecovery of kidney function requiring chronic dialysis within 
Statistical Analysis
We compared baseline characteristics between Métis citizens and the general population using standardized differences. 17 The incidence of study outcomes (acute kidney injury and end-stage kidney disease) were calculated as time to first event between April 1, 2003, and March 31, 2012. The prevalence of chronic kidney disease was defined by the presence of at least one code between April 1, 2003, and March 31, 2012. The risk of incident acute kidney injury and end-stage kidney disease for Métis citizens relative to the general population was assessed using Cox proportional hazards regression, stratified on the matched sets. The risk of prevalent chronic kidney disease was assessed using a modified Poisson regression, accounting for matched sets. In a secondary analysis, binary outcomes in follow-up after an in-hospital acute kidney injury episode were evaluated using chi-square tests. For these secondary outcomes, the matched nature of the data was not accounted for, as the low number of acute kidney injury hospitalizations did not permit matched analyses in this subset of individuals. The length of stay of the hospitalization with acute kidney injury was compared between the Métis citizens and general population groups using Wilcoxon signed-rank test. All analyses were conducted using SAS Version 9.3 (SAS Institute, Cary, NC). In all analyses, we interpreted 2-tailed P values less than 0.05 as statistically significant.
Results
A flow diagram of the cohort selection is shown in Figure 1 . As of April 1, 2003, there were 14 021 Métis citizens in the MNO registry. After applying exclusion criteria, a total of 12 229 registered Métis citizens were successfully matched to 48 916 adults from the general population. Individuals were followed for a median of 9.0 years (interquartile range [IQR], 9.0-9.0). Reasons for ending the observation time included death (4.0% overall; 3.7% Métis and 4.1% general population), emigration (6.0% overall; 4.2% Métis and 6.5% general population), kidney transplant (0.4% overall; 0.4% Métis and 0.4% general population), and reaching the study accrual end date of March 31, 2012 (88.5% overall; 90.7% Métis and 88.0% general population). The total observation time was 521 700 person-years (105 595 Métis and 416 105 general population).
Baseline characteristics are shown in Table 1 . As a result of matching, most baseline characteristics were similar between groups. In both groups, the median age was 41 years (IQR, 30-51), 46% were female, and a similar proportion resided in each of the 14 Local Health Integration Networks in Ontario. However, compared with the general population, Métis citizens had a higher number of primary care visits in the year preceding cohort entry (median 3 [IQR, 1-6] vs 2 [IQR, 0-5]).
Chronic Kidney Disease
In the year before April 1, 2003, approximately 5% of individuals in our study cohort had at least one laboratory test for serum creatinine (576 Métis citizens and 2304 in the general population) ( Table 2) . Among these individuals, the baseline prevalence of chronic kidney disease (defined as an eGFR below 60 mL/min/1.73 m 2 ) was 6.1% and 4.3%, respectively (relative risk [RR], 1.45; 95% confidence interval [CI], 1.04-2.02; P = 0.03). When stratified by severity of chronic kidney disease, we found similar estimates but these were not statistically significant. The prevalence of chronic kidney disease during follow-up (as defined using validated administrative health care codes in the entire cohort) was 3.1% among Métis citizens and 2.6% in the general population (RR 1.19; 95% CI, 1.07-1.32; P = 0.002).
Acute Kidney Injury
Similar to the assessment of chronic kidney disease above, approximately 5% of the cohort had baseline serum creatinine values in the year prior to April 1, 2003. When defined using inpatient or emergency department laboratory tests, the incidence of acute kidney injury during follow-up was 1.6 per 1000 person-years among Métis citizens, a rate not statistically different than the 1.2 per 1000 person-years observed in the general population (P = 0.89). Similarly, when defined using inpatient diagnosis codes, the incidence of acute kidney injury was not significantly different between groups (1.2 per 1000 person-years among Métis citizens versus 1.2 among the general population; P = 0.54).
Outcomes for individuals who were hospitalized with acute kidney injury (defined using diagnostic codes) are shown in Table 3 . Most outcomes did not differ between groups, including duration of hospital stay, death during hospitalization, short-term dialysis during hospitalization, and non-recovery of kidney function requiring dialysis. However, death within 1 year of hospital discharge was significantly higher among Métis citizens compared with the general population (26 of 106; 24.5% vs 59 of 386; 15.3%, respectively; P = 0.03).
End-Stage Kidney Disease
The incidence of end-stage kidney disease during follow-up was similar between groups: 2.2 per 10 000 person-years among Métis citizens and 2.4 per 10 000 person-years among the general population (P = 0.73).
Sensitivity Analyses
To examine whether matching on geographic location influenced our results, we removed this criterion in sensitivity analyses, but found no appreciable change in the results (data not shown).
Discussion
This research represents the first population-based study of kidney disease among registered Métis citizens of Ontario. We found that rates of acute kidney injury and end-stage kidney disease were similar for Métis citizens in Ontario and a matched general population sample. However, we did find a slightly higher prevalence of chronic kidney disease among Métis citizens compared with the general population (45% and 19% relative increase when using laboratory values and administrative codes to define chronic kidney disease, respectively). The 45% relative increase should be interpreted with caution, because event rates were small and the CI was wide. Furthermore, the absolute risk differences were small (0.5% when using administrative codes and 1.8% when using laboratory values). The chronic kidney disease prevalence in the general population for our study (2.6% and 4.3% defined by administrative codes and laboratory values, respectively) is consistent with a previous study which estimated chronic kidney disease prevalence in the general population of Canada measured by laboratory values as 3.1%. 18 Several previous studies have used Ontario's administrative health care data to examine the prevalence of chronic diseases in registered Métis citizens compared with the general population. These studies found elevated rates of related diseases such as diabetes and cardiovascular disease among Métis citizens, which aligns with our finding of a slightly higher prevalence of chronic kidney disease. [19] [20] [21] These previous studies on rates of diabetes and cardiovascular disease reported age and sex standardized results, 19, 22 where our findings were based on Métis citizens matched to the general population on age, sex, and area of residence.
Importantly, results were unchanged when we removed the matching criterion for area of residence, suggesting that rates of kidney disease are similar between Métis citizens and the age-matched and sex-matched general population in Ontario, regardless of geographic location. This is important because the majority of Métis citizens reside in smaller urban communities in Northern Ontario with potentially less access to health care compared with the general Ontario population. 9 In this study, rates of hospitalization with acute kidney injury were similar for Métis citizens and the general population. In a secondary analysis, we found that a significantly higher proportion of Métis citizens died within 1 year of hospital discharge; however, it is important to interpret this result with caution given that this secondary analysis was conducted in a very small subsample of the original cohort (106 Métis and 386 individuals from the general population) and spurious findings can arise in multiple subgroup comparisons. As well, the small number of events meant we were unable to retain the matching on baseline characteristics and so these results could be influenced by between-group differences in age, sex, and area of residence or also by higher comorbidities among Métis citizens, which has been documented in other reports. 8, 19, 21, 22 Nonetheless, even if this result could be explained by differences in baseline risk, from a public health perspective, a potentially higher rate of mortality in this subgroup is a cause for concern and requires further investigation, particularly with respect to follow-up care after acute kidney injury. The Acute Kidney Injury Guidelines set by Kidney Disease Improving Global Outcomes (KDIGO) 23 recommend that patients diagnosed with acute kidney injury be evaluated 3 months after the episode. While we were not able to examine follow-up care in the present study due to small sample sizes, future investigations should examine the overall quality of care and whether appropriate follow-up care occurs after an episode of acute kidney injury.
Previous research shows that Indigenous people living in Canada have rates of kidney disease that are 2 to 3 times higher compared with the general population. 1, 24, 25 However, when we looked specifically at the Métis population, we found that registered Métis citizens had rates of kidney disease that were similar, or only slightly higher, compared with a matched sample from the general population. The Métis are a distinct Indigenous people, and it is possible that a potentially lower risk among the Métis population may be explained by genetic or environmental factors or by differences in the way health care is provided, for example, via provincial or federal jurisdictions. 26 As well, Métis do not live on reserves and are more likely to reside in urban centres, 27 which may provide better access to health care. A 2004 CIHI report found that several social and economic indicators of health (including income, employment, and education levels) were lower among First Nations people compared with Métis people. 8 The Métis are the fastest growing Indigenous population in Canada, so it is important to continue further investigation of kidney outcomes in this population. 9 
Limitations
It is important to consider that the Citizenship Registry of the MNO captures only about 20% of the total Métis population in Ontario and may not be representative of the entire Métis population in Ontario. The registry is populated by individuals who choose to register, and registered citizens may differ from nonregistered citizens on important demographic, behavioral, and clinical factors. For example, some Métis may be motivated to register to gain certain benefits, such as access to harvesting and hunting rights, an activity more likely to be pursued by healthier individuals. These selection biases may have affected our rates of kidney disease, and our estimates may not be generalizable to the wider Métis population residing in Ontario.
Administrative data are widely used for the surveillance of chronic diseases because it is an efficient method to obtain measures on the burden of a disease for an entire population. The health administrative data in Ontario are held at ICES, making them readily available and can be linked to many other databases to create cohorts of the entire Ontario population. However, administrative data have limitations including a lack of comprehensive clinical detail, coding errors, and potential biases related to the method of data collection, such as physician claims data. We have previously shown that the administrative health care codes used to identify kidney disease are highly specific but lack sensitivity. 14, 16 In other words, there is a low false positive rate, but not all patients with kidney disease will be captured. Specifically, older patients with administrative diagnostic codes for chronic kidney disease had lower eGFR values than individuals without these codes (38 vs 69 mL/min/1.73 m 2 ). 14 Also, in a previous validation study, we showed that hospitalized patients with a diagnostic code for acute kidney injury had a median increase in serum creatinine of 98 µmol/L (IQR, 43-200) from their prehospitalization baseline value. By contrast, hospitalized patients with no diagnostic code for acute kidney injury had a median serum creatinine increase of 6 µmol/L (IQR, −4-20). 16 While we also assessed kidney disease using laboratory tests for serum creatinine, our hospital laboratory data used to assess acute kidney injury incidence are limited to a subsample of individuals who visit a Cerner hospital in Southwestern Ontario (only 5% of the study cohort). With regard to outpatient values used to identify prevalence of chronic kidney disease and baseline values to assess acute kidney injury, we only used laboratory data from Dynacare, which is 1 of the 3 largest outpatient laboratories in Ontario. Since the laboratory data is not available for all of Ontario, it is underestimating the true burden of acute kidney injury and chronic kidney disease in both populations. We are in the process of acquiring the Ontario Laboratories Information System (OLIS) database, which will have all outpatient laboratory tests completed in Ontario, including proteinuria data. We plan to conduct further analyses on this cohort once OLIS becomes available to use. Another important limitation of both administrative and laboratory data is that it only captures those who have accessed the health care system. This is an important issue for studies of the Métis population since we know from other studies that Métis citizens are less likely to access physician and/or specialist services compared with the non-Aboriginal population, suggesting a significant potential for both underdiagnosis and undertreatment of chronic disease relative to the general population in Ontario. 28 While it is possible that access may be different between the Métis and general population in our study, it is not likely since the baseline health care use of these 2 groups was similar. Finally, as we cannot identify nonregistered Métis citizens in our data sets, these individuals may have been included in our matched general population sample.
Conclusions
In this 10-year study of kidney disease among registered Métis citizens and a matched sample from the general Ontario population, we found a slightly higher prevalence of chronic kidney disease and similar incidence rates of acute kidney injury and end-stage kidney disease. Although these results are reassuring, further research is needed to replicate findings and inform practice. 
